The next generation of immunotherapies for lung cancers Summary Next-generation lung cancer immunotherapies are expanding beyond traditional checkpoint inhibitors like PD-1/PD-L1 antibodies. Scientists are exploring novel targets and approaches to overcome resistance and improve Read More
Tags :Cancer microenvironment
Education, Research & Positions
Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a
Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a phase 2 trial Summary This phase 2 trial explores a novel approach to overcome resistance to anti-PD-1 immunotherapy in triple-negative breast cancer (TNBC). Researchers aim to Read More
Site Logo
Powered by AI
New Journal Citation Reports (JCR) 2025
All-Time Views
930K+ and Counting..!
Follow me on Linkedin for Latest Jobs and Scholarships
Join WhatsApp
Click the ICON to Join
Subscribe Youtube
Celebrating 6 Years
Now, it has been 6 years since it was launched in late July 2018 and is moving forward. Appreciate all the respected visitors! Please share this site with your friends to push science forward and improve human health.
Site Trust Score
Google Safe
